未名医药: 关于董事、高级管理人员薪酬方案的公告

Core Points - The company, Shandong Weiming Bio-Pharmaceutical Co., Ltd. (referred to as "Weiming Pharmaceutical"), is proposing a compensation plan for its directors and senior management to enhance governance and incentivize performance [1][2] - The compensation plan for directors requires approval from the shareholders' meeting to be implemented [1] - The independent directors will receive an annual allowance of RMB 100,000 (pre-tax), paid biannually [2] - Non-independent directors holding other management positions will receive compensation based on their roles and performance evaluations, without additional director allowances [2] - Senior management compensation will be determined by their positions and responsibilities, with basic salaries paid monthly and performance bonuses based on company and individual performance [2] Summary by Sections Applicable Parties - The compensation plan applies to the company's directors and senior management [1] Duration of the Plan - The director compensation plan will take effect upon approval by the shareholders' meeting, while the senior management plan will take effect after the board's approval [1] Compensation Details - Independent directors will receive a pre-tax allowance of RMB 100,000 per year, distributed biannually [2] - Non-independent directors without management roles will also receive the same allowance [2] - Senior management will receive a basic salary based on their roles, with performance-based compensation linked to company performance and individual contributions [2] Other Provisions - Reasonable expenses incurred while performing duties will be covered by the company [2] - The compensation plan must comply with national and local laws and regulations [2]